Florent Beaufils

Biography

Florent has over 10 years of accomplishments in the Pharma/Biotech industry. His professional experience includes the discovery, process and preclinical development of various protein kinase inhibitors for the treatment of cancer (PQR309, FDA Orphan Drug Designation in 2016) and CNS disorders (PQR620), and a successful technology transfer (2009) with New England Biolabs (SNAP-tag®, CLIP-tag™). Florent received his Ph.D. in Organic Chemistry at the University of Bern in 2004, and carried out postdoctoral work on total synthesis with Alois Fürstner at the Max Planck Institute für Kohlenforschung in 2005. He was Head of Chemistry and Quality Control at Covalys Biosciences AG (Switzerland) (2005 - 2009), Senior Researcher at the Department of Biomedicine of the University of Basel (2009 - 2012) and Deputy Head of Chemistry at PIQUR Therapeutics AG (2012 - 2016). Florent is co-author of numerous high impact scientific publications and co-inventor of 10 patents in the areas of drug discovery, process development and biological research.

Research Interest

discovery, process and preclinical development of various protein kinase inhibitors for the treatment of cancer (PQR309, FDA Orphan Drug Designation in 2016) and CNS disorders (PQR620), and a successful technology transfer (2009) with New England Biolabs (SNAP-tag®, CLIP-tag™)